Catalyst Awardee

Project Description

Curing infected wounds effectively with the most advanced antibacterial wound dressing

Olesja Bondarenko, PhD |
Nanordica Medical, CEO; National Institute of Chemical Physics and Biophysics; Anna-Liisa Kubo, PhD; Grigory Vasiliev, MD
Competition Sponsor:
EIT Health of the European Union
Awardee Year: 2022

Nanordica Medical is Estonian deep tech company developing advanced antibacterial wound care products to reduce infection-related amputations. Our first product, antibacterial wound dressing, eliminates wound infections 8 times better than the current commercial best according to pre-clinical data. In Q3 2022 we are starting the first pilot clinical trial of our wound dressing on patients with infected diabetic foot ulcers. Our dressing is suitable for different types of acute as well as chronic wounds. Our ultimate vision is to help hundreds of millions of patients with wounds.

See our video:

Contact our CEO:


To learn more about this proposal, email

Sign up for updates